|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
|
Columbia
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2026 | 715 GMAT Focus | 3.7 | 5 | Other | India |
09 Feb 2026 09:28 PM
|
|
Ross (Michigan)
Full Time MBA |
Interviewed
|
Round 2 | 2026 | 3.9 | 5 | Consulting | China |
09 Feb 2026 08:54 PM
|
|
|
IESE
Full Time MBA |
Interviewed
|
Round 2 | 2026 | 655 GMAT Focus 169 EA |
3.9 | 5 | Finance: Venture Capital | United States |
09 Feb 2026 04:32 PM
|
|
Columbia
Full Time MBA |
Invited to Interview
|
Round 2 | 2026 | 655 GMAT Focus 169 EA |
3.9 | 5 | Finance: Venture Capital | United States |
09 Feb 2026 04:32 PM
|
|
Scheller
Full Time MBA |
Denied without Interview
|
Round 2 | 2026 | 715 GMAT Focus | 3.2 | 11 | Technology | Viet Nam |
09 Feb 2026 02:24 PM
|
|
Foster
Full Time MBA |
Denied without Interview
|
Round 2 | 2026 | 715 GMAT Focus | 3.2 | 11 | Technology | Viet Nam |
09 Feb 2026 02:24 PM
|
|
Anderson
Full Time MBA |
Invited to Interview
|
Round 2 | 2026 | 715 GMAT Focus | 3.2 | 11 | Technology | Viet Nam |
09 Feb 2026 02:24 PM
|
|
Yale
Full Time MBA |
Admitted
|
2026 | 339 GRE | 8.9 | 4 | Technology | India |
09 Feb 2026 01:21 PM
|
|
|
Sloan MIT
Full Time MBA |
Waitlisted without Interview
|
2026 | 339 GRE | 8.9 | 4 | Technology | India |
09 Feb 2026 01:21 PM
|
|
|
Kellogg
Full Time MBA |
Admitted
|
2026 | 339 GRE | 8.9 | 4 | Technology | India |
09 Feb 2026 01:21 PM
|
|
|
HEC Paris
September Intake |
Denied without Interview
|
Round 2 | 2026 | 575 GMAT Focus 575 GMAT Focus 316 GRE |
8.3 | 5 | Other | India |
09 Feb 2026 10:25 AM
|
|
IE
September Intake Class of |
Admitted
|
Rolling | 2026 | 575 GMAT Focus 575 GMAT Focus 316 GRE |
8.3 | 5 | Other | India |
09 Feb 2026 10:25 AM
|
|
IIM (All Schools)
IIM Ahmedabad PGPX |
Admitted
|
2026 | 220 GMAT Classic | 4 | 2 | Finance: Investment Banking | India |
09 Feb 2026 10:05 AM
|
|
|
Harvard
Full Time MBA |
Denied without Interview
|
Round 2 | 2026 | 3.9 | 4 | Healthcare/Pharmaceuticals | United States |
09 Feb 2026 08:51 AM
|
|
|
Harvard
Full Time MBA |
Denied without Interview
|
Round 2 | 2026 | 605 GMAT Focus | 8.5 | 6 | Other | Brazil |
09 Feb 2026 06:30 AM
|
|
HEC Paris
HEC MiM |
Admitted
|
R1 | 2026 | 575 GMAT Focus | 2 | 1 | Consulting | Thailand |
09 Feb 2026 06:18 AM
|
|
LBS
Full Time MBA |
Admitted
|
2026 | 685 GMAT Focus 334 GRE |
9.4 | 4 | Consulting | India |
08 Feb 2026 05:51 PM
|
|
|
Yale
Full Time MBA |
Admitted
|
2026 | 685 GMAT Focus 334 GRE |
9.4 | 4 | Consulting | India |
08 Feb 2026 05:51 PM
|
|
|
Sloan MIT
Full Time MBA |
Denied without Interview
|
2026 | 685 GMAT Focus 334 GRE |
9.4 | 4 | Consulting | India |
08 Feb 2026 05:51 PM
|
|
|
Kellogg
Full Time MBA |
Admitted
|
2026 | 685 GMAT Focus 334 GRE |
9.4 | 4 | Consulting | India |
08 Feb 2026 05:51 PM
|